+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Polycystic Kidney Disease Market - Product Thumbnail Image

Polycystic Kidney Disease Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
VEMLIDY Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

VEMLIDY Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
ASC22 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

ASC22 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
OXLUMO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OXLUMO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
Alagille syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alagille syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Kidney Transplantation Therapeutics Market 2024-2028 - Product Thumbnail Image

Kidney Transplantation Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 171 Pages
  • Global
From
Renal Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 160 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more